INFLUENCE OF CANNABINOID RECEPTOR GPR55 UPON SALIVATION OF RAT SUBMANDIBULAR SALIVARY GLAND
DOI: http://dx.doi.org/10.30970/sbi.0703.314
Abstract
This paper is devoted to elucidation of functionally active cannabinoid receptor GPR55 in submandibular salivary gland cells of rats by introducing a specific agonist lysophosphatidylinositol. We studied the effect of GPR55 activation on the following parameters of basal salivation in vivo: rate of salivation of protein concentration and electrolytes. It was shown that in vivo activation of cannabinoid receptor GPR55 in the acinar cells of submandibular salivary gland by lysophosphatidylinositol caused a dose-dependent reduction in basal flow of saliva. We also elucidated that activation of the cannabinoid receptor GPR55 induced an increase of concentration of total protein in saliva secreted in vivo. That indicate that the activation of cannabinoid receptor GPR55 leads to an enhancement of exocytosis of secretory vesicles in acinar cells. We showed that under conditions of activation of cannabinoid receptor GPR55, changes also occured in concentration of electrolytes in basal saliva such as: reduction in concentration of calcium (Ca2+), inorganic phosphorus (Pi), and increasing concentration of potassium (K+). Based on these findings, we suggest that activation of cannabinoid receptor GPR55 leads to modulation of intracellular signaling mechanisms involved in the secretion of water and electrolytes in acinar cells of rat submandibular salivary gland.
Keywords
Full Text:
PDF (Українська)References
1. Копач О., Федірко Н. Кальцій-залежні зміни функціонування ацинарних клітин слинних залоз у разі дії агоністів холінергічної природи. Вісник Львів. ун-ту. Сер. біол, 2004; 37: 205-212. | |
| |
2. Нецик О., Гричан Н., Копач О., Федірко Н. Роль канабіноїдних рецепторів у регуляції слиновиділення підщелепною слинною залозою щурів. Вісник Львів. ун-ту. Сер. біол, 2009; 50: 131-143. | |
| |
3. Нецик О., Федірко Н. Ендоканабіноїди регулюють процеси слиновиділення через модуляцію процесів кальцієвої сигналізації. Вісник Львів. ун-ту. Сер. біол, 2010; 52: 152-162. | |
| |
4. Abood M.E., Sorensen R.G., Nephi S. Endocannabinoids: Actions at Non-CB1/CB2 Cannabinoid Receptors. ISBN, 2013; 978: 4614-4669. | |
| |
5. Barnett R.N., Skodon S.B., Goldberg M.H. Performance of "kits" used for clinical chemical analysis of calcium in serum. Am. J. Clin. Pathol,1973; 59: 836-845. | |
| |
6. Bondarenko A., Waldeck-Weiermair M., Graier W.F. GPR55-dependent and -independent ion signaling in response to lysophosphatidylinositol in endothelial cells. British Journ. of Pharmacology, 2010; 161: 308-320. | |
| |
7. Duncan M., Mouihate A., Mackie K. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am. J. Physiol. Gastrointest. Liver Physiol, 2008; 295: G78-G87. | |
| |
8. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev, 2003; 83: 1017-1066. | |
| |
9. Henry R. J. Clinical Chemistry - Principles and Techniques. Harper and Row, New York, 1974; 664-666. | |
| |
10. Henstridge C. M., Balenga A. B., Ford L. A. The GPR55 ligand L-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. The FASEB Journ, 2009; 23: 183-193. | |
| |
11. Hiley C.R., Kaup S.S. GPR55 and the vascular receptors for cannabinoids. British Journ. of Pharmacology, 2007; 152: 559-561. | |
| |
12. Hillmann J.J. Biochemical and Clinical Actions. Clin.Chem. and Clin. Biochem, 1967; 5: 93-95. | |
| |
13. Kano M., Ohno-Shosaku T., Hashimotodani Y. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev, 2009; 89: 309-380. | |
| |
14. Kikuchi A., Ohashi K., Sugie Y. Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity. J. Pharmacol. Sci, 2008; 106: 219-224. | |
| |
15. Kopach O., Vats J., Netsyk O. Cannabinoid receptors in submandibular acinar cells: functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling. J. Cell Sci, 2012; 125(Pt 8): 1884-95 | |
| |
16. Lauckner J.E., Jensen J.B., Chen Huei-Ying. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. PNAS, 2008; 105(7): 2699-2704. | |
| |
17. Lowry O.H., Rosebrough N.J., Farr L.A. Protein measurement with the folin phenol reagent. J. Biol. Chem, 1951; 193: 265-275. | |
| |
18. Massa F., Storr M., Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J. Mol. Med, 2005; 83: 944-954. | |
| |
19. Matsuda L.A. Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol, 1997; 11: 143-166. | |
| |
20. Matsuda L A., Lolait S.J., Brownstein M.J. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990; 346: 561-564. | |
| |
21. Matsuo S., Lagerlof F. Relationship between total and ionized calcium concentrations in human whole saliva and dental plaque fluid. Arch. Oral. Biol, 1991; 36: 525-527. | |
| |
22. Pertwee R.G. GPR55: a new member of the cannabinoid receptor clan? Br. J. Pharmacol, 2007; 152(7): 984-986. | |
| |
23. Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut, 2001; 48: 859-867. | |
| |
24. Prestifilippo J.P., Fernandez-Solari J., de la Cal, Iribarne M. et al. Inhibition of salivary secretion by activation of cannabinoid receptor. Exp. Biol. Med, 2006; 231: 1421-1429. | |
| |
25. Sanger G.J. Endocannabinoids and the gastrointestinal tract: what are the key questions? Br. J. Pharmacol, 2007; 152: 663-670. | |
| |
26. The endocannabinoid system. Handbook. ECSN, 2009. 96 p. | |
| |
27. Wright K.L., Duncan M., Sharkey K.A. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br. J. Pharmacol, 2008; 153: 263-270. | |
Refbacks
- There are currently no refbacks.
Copyright (c) 2013 Studia biologica
This work is licensed under a Creative Commons Attribution 4.0 International License.